Galafold® (migalastat) & Women With Fabry
> Effects

Rebecca, an actual Galafold patient.

Your Fabry disease deserves to be recognized, acknowledged, and monitored.

Because Fabry is an X-linked disorder and women have two X chromosomes, the GLA gene that causes Fabry may work normally in some parts of the body but not others. This is believed to be one reason why women with Fabry have more variable symptoms than men.

Women with Fabry may experience all or just some of the effects of Fabry to different extents, or they might never feel any of them. Because symptoms can vary, it is important that you and your healthcare provider recognize that your symptoms can be caused by Fabry and address them appropriately.

Women and Fabry Brochure

See the common ways that Fabry can affect women.

Download

If you are a woman with Fabry disease who is experiencing symptoms, you are in the majority.

Nearly 70% Symptoms-Statistic

of women diagnosed with Fabry report having signs and symptoms of the disease.

Though women may first notice effects of Fabry when they are teenagers, they often have to wait years before finding out the cause.

10 Year Diagnostic Delay-Statistic

is the average amount of time between when women first notice effects of Fabry and when they receive a definitive Fabry diagnosis through laboratory testing.

As mentioned above, women can experience the effects of Fabry just as severely as men. For example, one survey looking at pain intensity, duration, and frequency as a result of Fabry disease in both genders showed that pain ratings from women were virtually indistinguishable from those of men.

However, regardless of if or how you are experiencing its symptoms, Fabry is a progressive disease, meaning damage is always happening even if you can’t see it. That’s why it’s so important to keep an eye on your disease, as it can inform what steps you and your healthcare team take in managing your Fabry disease.

IN HER WORDS: BE HEARD

Hear from Rebecca, a Galafold patient and mother to a son with Fabry, who challenged a reluctance to diagnose and manage her Fabry because of her gender.

Hear from Rebecca, a Galafold patient and mother to a son with Fabry, who challenged a reluctance to diagnose and manage her Fabry because of her gender.

Interactive Fabry Discussion Guide

Fabry Discussion Driver

Take the wheel at your next appointment and cover what matters most to you.

Start now

Next Up: From diagnosis through treatment of Fabry disease, you are your own best advocate.

IMPORTANT SAFETY INFORMATION AND INDICATION

Before taking Galafold® (migalastat), tell your healthcare provider about all of your medical conditions, including if you:

  • have kidney problems.
  • are pregnant or plan to become pregnant. It is not known if Galafold will harm your unborn baby.
  • have kidney problems.
  • are pregnant or plan to become pregnant. It is not known if Galafold will harm your unborn baby.
  • are breastfeeding or plan to breastfeed. Galafold may pass into breast milk. Talk to your healthcare provider
    about the best way to feed your baby if you take Galafold.

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

What are the possible side effects of Galafold?

The most common side effects of Galafold include headache, stuffy or runny nose and sore throat, urinary tract infection, nausea, and fever.

These are not all the possible side effects of Galafold. Call your healthcare provider for medical advice about side effects.

What is Galafold?

Galafold is a prescription medicine used to treat adults with Fabry disease who have a certain genetic change (variant) in the galactosidase alpha gene (GLA) that is responsive (amenable) to Galafold.

It is not known if Galafold is safe and effective in children.

You may report side effects to FDA at 1-800-FDA-1088. You may also report side effects to Amicus Therapeutics at 1-877-4AMICUS.

Please click here for Full Prescribing Information, including Patient Information and Instructions for Use.

Down arrow